To contain pharmaceutical spending, drug budgets have been introduced across health
systems. Apart from analyzing whether drug budgets fulfill their overall goal of reducing …

Since their introduction in 1993, the structure of physician drug budgets in Germany has
changed frequently. Although highly disputed, they have limited the pharmaceutical …

In many health care markets, physicians can respond to changes in reimbursement
schemes by changing the volume (volume response) and the composition of services …

Health care payers try to reduce costs by promoting the use of cheaper generic drugs. We
show strong interrelations in drug prescriptions between the inpatient and outpatient sectors …

While most countries separate drug prescription and dispensation to ensure independent
drug choice, some allow this combination to increase pharmaceutical access in rural areas …

Spending on prescription drugs (Rx) represents one of the fastest growing components of
US healthcare spending and has coincided with an expansion of pharmaceutical …

Objectives We analyzed the effect of the outpatient prescription incentive program and price
cuts of listed medicines in South Korea on prescription drug expenditures and prescription …

Aim: To explain the components of pharmaceutical expenditure and illustrate the strengths
and limitations of this indicator. In particular, we explore policies applied in European …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Many politicians blame physician dispensing (PD) to increase health care expenditure and
to undermine independence of drug prescription and income leading to a suboptimal …